Literature DB >> 8162014

Distribution of wild-type and common deletion forms of mtDNA in normal and respiration-deficient muscle fibers from patients with mitochondrial myopathy.

M Sciacco1, E Bonilla, E A Schon, S DiMauro, C T Moraes.   

Abstract

We studied the cellular distribution of both deleted (delta) and wild-type (wt) mitochondrial DNAs (mtDNAs) in 'normal' and respiration-deficient muscle fibers from four patients with mitochondrial myopathy. PCR-based methods were used to quantitate both relative and absolute amounts of delta- and wt-mtDNAs in microdissected fiber segments. Although delta-mtDNAs were present in normal fibers (31% +/- 26), their percentages were much higher in affected fibers (95% +/- 2). Absolute levels of delta-mtDNA were also increased in affected fibers, whereas levels of wt-mtDNA were significantly reduced in these fibers. These results indicate that a threshold ratio of delta-/wt-mtDNA must be achieved before an impairment of respiration is observed in muscle. Moreover, the marked reduction in wt-mtDNA observed in affected fibers suggests that absolute amounts of mtDNA may play a role in the pathogenesis of mitochondrial myopathies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8162014     DOI: 10.1093/hmg/3.1.13

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  79 in total

Review 1.  Mitochondrial threshold effects.

Authors:  Rodrigue Rossignol; Benjamin Faustin; Christophe Rocher; Monique Malgat; Jean-Pierre Mazat; Thierry Letellier
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

2.  Mitochondrial DNA damage as a potential mechanism for age-related macular degeneration.

Authors:  Pabalu P Karunadharma; Curtis L Nordgaard; Timothy W Olsen; Deborah A Ferrington
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-05-26       Impact factor: 4.799

Review 3.  Mitochondrial DNA mutations in human disease.

Authors:  Robert W Taylor; Doug M Turnbull
Journal:  Nat Rev Genet       Date:  2005-05       Impact factor: 53.242

4.  Absolute quantitation of a heteroplasmic mitochondrial DNA deletion using a multiplex three-primer real-time PCR assay.

Authors:  Bobby G Poe; Marian Navratil; Edgar A Arriaga
Journal:  Anal Biochem       Date:  2006-12-22       Impact factor: 3.365

5.  Maternally inherited cardiomyopathy and hearing loss associated with a novel mutation in the mitochondrial tRNA(Lys) gene (G8363A).

Authors:  F M Santorelli; S C Mak; M El-Schahawi; C Casali; S Shanske; T Z Baram; R E Madrid; S DiMauro
Journal:  Am J Hum Genet       Date:  1996-05       Impact factor: 11.025

6.  Myoclonic epilepsy and ragged red fibers (MERRF) syndrome: selective vulnerability of CNS neurons does not correlate with the level of mitochondrial tRNAlys mutation in individual neuronal isolates.

Authors:  L Zhou; A Chomyn; G Attardi; C A Miller
Journal:  J Neurosci       Date:  1997-10-15       Impact factor: 6.167

7.  Heterogeneous nuclear ribonucleoprotein A2 is a common transcriptional coactivator in the nuclear transcription response to mitochondrial respiratory stress.

Authors:  Manti Guha; Hua Pan; Ji-Kang Fang; Narayan G Avadhani
Journal:  Mol Biol Cell       Date:  2009-07-29       Impact factor: 4.138

8.  Normal levels of wild-type mitochondrial DNA maintain cytochrome c oxidase activity for two pathogenic mitochondrial DNA mutations but not for m.3243A-->G.

Authors:  Steve E Durham; David C Samuels; Lynsey M Cree; Patrick F Chinnery
Journal:  Am J Hum Genet       Date:  2007-05-23       Impact factor: 11.025

9.  PGC-1alpha/beta induced expression partially compensates for respiratory chain defects in cells from patients with mitochondrial disorders.

Authors:  Sarika Srivastava; Francisca Diaz; Luisa Iommarini; Karine Aure; Anne Lombes; Carlos T Moraes
Journal:  Hum Mol Genet       Date:  2009-03-18       Impact factor: 6.150

10.  Lack of mitochondrial DNA deletions in lesions of multiple sclerosis.

Authors:  Andrei Blokhin; Tamara Vyshkina; Samuel Komoly; Bernadette Kalman
Journal:  Neuromolecular Med       Date:  2008       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.